Amphotericin B resistance correlates with increased fitness in vitro and in vivo in Leishmania (Mundinia) martiniquensis

Amphotericin B (AmpB) deoxycholate is the available first-line drug used to treat visceral leishmaniasis caused by Leishmania (Mundinia) martiniquensis, however, some cases of AmpB treatment failure have been reported in Thailand. Resistance to drugs is known to affect parasite fitness with a potent...

Descripción completa

Detalles Bibliográficos
Autores principales: Mano, Chonlada, Kongkaew, Aphisek, Tippawangkosol, Pongsri, Somboon, Pradya, Roytrakul, Sittiruk, Pescher, Pascale, Späth, Gerald F., Uthaipibull, Chairat, Tantiworawit, Adisak, Siriyasatien, Padet, Jariyapan, Narissara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116047/
https://www.ncbi.nlm.nih.gov/pubmed/37089544
http://dx.doi.org/10.3389/fmicb.2023.1156061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116047/
https://www.ncbi.nlm.nih.gov/pubmed/37089544
http://dx.doi.org/10.3389/fmicb.2023.1156061

Ejemplares similares